Research map: Feasibility of epidermal growth factor receptor and Kirsten rat sarcoma viral oncogene homolog mutation testing in non-plasma body fluids with low tumor cellularity using Idylla®: A proof-of-concept

Back to the article

Papers in this map

  1. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Andrès M.R. Cervantes · 2022 · 1801 citations · Cited by this paper
  2. Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer · 2025 · Related
  3. Liquid biopsy in cancer: current status, challenges and future prospects · Liwei Ma · 2024 · 686 citations · Cited by this paper
  4. Tripartite motif-containing protein 28 promotes drug resistance to bortezomib in gastric cancer through proteasome activity regulation · 2026 · Related
  5. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Thierry Conroy · 2023 · 593 citations · Cited by this paper
  6. Diagnostic accuracy of the Yokohama system for reporting breast fine-needle aspiration cytology and breast imaging-reporting and data system in breast lesions · 2026 · Related
  7. Molecular genetic testing and the future of clinical genomics · Sara Huston · 2013 · 440 citations · Cited by this paper
  8. A case of inappropriate thyroid-stimulating hormone secretion syndrome after thalidomide treatment · 2026 · Related
  9. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group · Maria Fernanda Mosele · 2024 · 409 citations · Cited by this paper
  10. Comparative evaluation of junctional adhesion molecule 3 and paired box gene 1 methylation, cytology, E6/E7 messenger RNA, and high-risk human papillomavirus testing for detecting precancerous cervical lesions · 2026 · Related
  11. ESMO Recommendations on clinical reporting of genomic test results for solid cancers · Joris van de Haar · 2024 · 64 citations · Cited by this paper
  12. Long non-coding RNA LOC101926915-encoded micropeptide carboplatin-induced upregulation factor confers carboplatin resistance in ovarian cancer · 2026 · Related
  13. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA · Sandra R. Faias · 2018 · 33 citations · Cited by this paper
  14. Transcription factor EGR1 orchestrates ferroptosis to mitigate sepsis-induced myocardial injury by enhancing ferroportin expression · 2026 · Related
  15. Evaluation, Validation, and Implementation of the Idylla System as Rapid Molecular Testing for Precision Medicine · Huiya Huang · 2019 · 32 citations · Cited by this paper
  16. Myxoid spindle cell lipoma of the ileum: Clinicopathological features and diagnostic insights · 2026 · Related
  17. Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor! · Lucile Durin · 2020 · 31 citations · Cited by this paper
  18. Topoisomerase II binding protein 1-interacting checkpoint and replication regulator promotes lung adenocarcinoma proliferation by regulating myelocytomatosis oncogene signaling pathway · 2026 · Related
  19. Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers · Hui-Ta Wu · 2022 · 23 citations · Cited by this paper
  20. Integrin β1 in osteoblast differentiation and migration during acute bone loss after fracture: Regulation of extracellular signal-regulated kinase 1/2 signaling pathway · 2026 · Related
  21. Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers · Pauline Gilson · 2021 · 16 citations · Cited by this paper
  22. Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer · Hampig Raphaël Kourié · 2024 · 8 citations · Cited by this paper
  23. Biomarker testing strategies in non-small cell lung cancer in the real-world setting: analysis of methods in the Prospective Central Lung Cancer Biomarker Registry (LungPath) from the Spanish Society of Pathology (SEAP) · Javier Martín-López · 2021 · 7 citations · Cited by this paper
  24. Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica · Dolores Isla · 2023 · 7 citations · Cited by this paper
  25. Pancreatic cyst fluid harboring a KRAS mutation · M. Rabie Al-Turkmani · 2019 · 4 citations · Cited by this paper
  26. Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing · Dingani Nkosi · 2023 · 4 citations · Cited by this paper
  27. Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series · Iris Dirven · 2024 · 3 citations · Cited by this paper
  28. Untitled · Cited by this paper

Source: OpenAlex (CC0)